MED: Medifast, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 2 sales totaling $226K in the last 180 days.
Insider sales
| Trade date | Insider | Role | Value | 10b5-1 plan |
|---|---|---|---|---|
| 2026-09-29 | Chard Daniel R | Director | $112K | yes |
| 2026-09-28 | Chard Daniel R | Director | $114K | yes |
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-21 | 13D amendment | Steamboat Capital Partners, LLC | 7.10% | SEC | |
| 2026-08-14 | Fell below 5% | Citadel Securities GP LLC | 2.60% | SEC | |
| 2026-08-14 | New 13G stake | Susquehanna Portfolio Strategies, LLC | 5.30% | SEC | |
| 2026-08-12 | Fell below 5% | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3.60% | SEC |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.